WW, Your view makes a lot of sense apart from
'Guaranteed, its de-risked but not yet approved. Once approved .....'
For me that is a dangerous overconfident statement. If approval was a foregone but future event, the potential value and current SP of the company would be (much) higher than now. Oh, that was the case and it was just a matter of sitting it out with no risk.
Granted, it is better than an even money chance for approval, but how much better is very hard to assess. Also, I consider the 'degree and breadth of efficacy' demonstrated will be a big factor in determing take up and thus how close actual income will be to predictions of milestones and dividends.
A good bet for those that hang on (provided we are not sold), but definitely no certainty in actually reaching the finish line, nor in subsequent value if we do.
- Forums
- ASX - By Stock
- NEU
- Goldman Sachs Healthcare Conference
Goldman Sachs Healthcare Conference, page-36
-
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.61 |
Change
0.000(0.00%) |
Mkt cap ! $1.995B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 191 | $16.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.83 | 950 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 191 | 16.590 |
3 | 368 | 16.390 |
1 | 55 | 16.340 |
1 | 105 | 16.320 |
1 | 1447 | 16.000 |
Price($) | Vol. | No. |
---|---|---|
14.830 | 950 | 4 |
15.040 | 12 | 1 |
15.150 | 126 | 5 |
15.430 | 29 | 3 |
15.550 | 148 | 1 |
Last trade - 09.46am 16/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online